Investigation of the İn Vitro Effect of Vanillic Acid on Wound Healing via FN1 and COL1α1 Genes

Year 2024, , 233 - 240, 14.06.2024

Yeşim Yeni

https://doi.org/10.5798/dicletip.1501313

Abstract

Objective: Wound healing is characterized by the removal of dead/damaged tissue, the formation of new tissue, and finally, the restoration of the damaged tissue to its original function, starting from the moment of tissue injury. Vanillic acid (VA) is an important component of wheat bran and can heal wounds thanks to its antioxidant potential. This work aimed to investigate the dose-dependent effects of VA (1-2-4-8-16 and 32 μg/ml) in an in vitro way using a wound healing pattern in fibroblast cells.
Methods: The MTT test was performed to determine cell viability 48 hours after VA application to the cells in which the wound model was created (except for the control and wound groups). The cells were examined morphologically with an inverted microscope. ELISA and Real-Time PCR analyses were performed to determine changes in oxidative stress parameters and FN1 and COL1α1 gene expressions.
Results: The highest percentage closure rate of fibroblast cells in the in vitro wound pattern analysis and the highest percentage of cell viability by MTT analysis were determined in the VA-32 treated group. Morphological images showed that the evaluated gene expressions increased in fibroblast cells in a VA dose-dependent manner.
Conclusion: Our findings demonstrated for the first time that VA promotes cell migration and proliferation by regulating oxidative stress and FN1A and COL1α1 genes. The results of this work are thought to pioneer the use of VA in in vivo wound healing studies.

Keywords

8-OHdG, Fibroblast, MTT, Vanillic acid

References

• 1.Parsak CK, Sakman G, Çelik Ü. Yara iyileşmesi, yarabakımı ve komplikasyonları. Arşiv Kaynak TaramaDergisi 2007;16(2):145-59.
• 2.Venus M, Waterman J, McNab I. Basic physiology of theskin. Surgery (Oxf) 2011; 29: 471-4.
• 3.Velnar T, Bailey T, Smrkolj V. The wound healingprocess: an overview of the cellular and molecularmechanisms. J Int Med Res 2009; 37: 1528-42.
• 4.Sen CK, Roy S. Redox signals in wound healing. BiochimBiophys Acta 2008; 1780:1348-61.
• 5.Jarnagin WR, Rockey DC, Koteliansky VE, et al.Expression of variant fibronectins in wound healing:cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 2013; 127:1-12.
• 6.Bielefeld KA, Amini-Nik S, Whetstone H, et al.Fibronectin and β-catenin act in a regulatory loop indermal fibroblasts to modulate cutaneous healing. J BiolChem 2011; 286: 27687-97.
• 7.Lenselink EA. Role of fibronectin in normal woundhealing. Int Wound J 2015; 12: 313-6.
• 8.Martino MM, Tortelli F, Mochizuki M, et al. Engineeringthe growth factor microenvironment with fibronectindomains to promote wound and bone tissue healing. SciTransl Med 2011; 3: 1-10.
• 9.Stevenson L, Phillips F, O'sullivan K, et al. Wheat bran:its composition and benefits to health, a Europeanperspective. Int J Food Sci Nutr 2012; 63:1001–13.
• 10.Itoh A, Isoda K, Kondoh M, et al. Hepatoprotectiveeffect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol Pharm Bull 2009; 32: 1215–9.
• 11.Sinha AK, Sharma UK, Sharma N. A comprehensivereview on vanilla flavor: extraction, isolation andquantification of vanillin and others constituents. Int JFood Sci Nutr 2008; 59: 299–326.
• 12.Amin FU, Shah SA, Kim MO. Vanillic acid attenuatesAβ1-42-induced oxidative stress and cognitiveimpairment in mice. Sci Rep 2017; 7: 40753.
• 13.Ingole A, Kadam MP, Dalu AP, et al. A review of thepharmacological characteristics of vanillic acid. J DrugDelivery Ther 2021; 11(2–S): 200-4.
• 14.Liguori I, Russo G, Curcio F, et al. Oxidative stress,aging, and diseases. Clin Interv Aging 2018; 13: 757–72.
• 15.Kaur J, Gulati M, Singh SK, et al. Discoveringmultifaceted role of vanillic acid beyond flavours:nutraceutical and therapeutic potential. Trends Food SciTechnol 2022; 122: 187-200.
• 16.Yalameha B, Nejabati HR, Nouri M. Cardioprotectivepotential of vanillic acid. Clin Exp Pharmacol Physiol2023; 50(3): 193–204.
• 17. Lashgari NA, Roudsari NM, Momtaz S, et al. Regulatorymechanisms of vanillic acid in cardiovascular diseases: areview. Curr Med Chem 2023; 30(22): 2562-76.
• 18. Altinoz MA, Yılmaz A, Taghızadehghalehjoughı A, et al.Ulipristal-temozolomide hydroxyurea combination forglioblastoma: in-vitro studies. J Neurosurg Sci 2022; 66:1-14.
• 19.Genc S, Cıcek B, Yenı Y, et al. Wound healing potentialof quinic acid in human dermal fibroblasts by regulatingthe expression of FN1 and COL1α genes. Tr J Nature Sci2022; 11(4): 63-9.
• 20.Yeni Y, Cakir Z, Hacimuftuoglu A, et al. A selectivehistamine H4 receptor antagonist, JNJ7777120, role onglutamate transporter activity in chronic depression. JPers Med 2022;12(2): 246.
• 21.Martin P, Nunan R. Cellular and molecularmechanisms of repair in acute and chronic woundhealing. Br J Dermatol 2015; 173(2): 370-8.
• 22.Fitzmaurice SD, Sivamani RK, Isseroff RR. Antioxidanttherapies for wound healing: a clinical guide to currentlycommercially available products. Skin Pharmacol Physiol2011; 24(3):113-26.
• 23.Kunkemoeller B, Kyriakides TR. Redox signaling indiabetic wound healing regulates extracellular matrixdeposition. Antioxid Redox Signal 2017; 27(12): 823-38.
• 24.Kang JI, Kim SC, Kim MK, et al. Effects ofdihydrotestosterone on rat dermal papilla cells in vitro.Eur J Pharmacol 2015; 757: 74–83.
• 25.Lian X, Zhao J, Wu X, et al. The changes in glucosemetabolism and cell proliferation in the kidneys ofpolycystic kidney disease mini-pig models. BiochemBiophys Res Commun 2017; 488: 374–81.
• 26.Kang J, Choi YK, Koh YS, et al. Vanillic acid stimulatesanagen signaling via the pı3k/akt/β-catenin pathway indermal papilla cells. Biomol Ther (Seoul) 2020; 28(4):354–60.
• 27.Fayet C, Bendeck MP, Gotlieb AI. Cardiac valveinterstitial cells secrete fibronectin and form fibrillaradhesions in response to injury. Cardiovasc Pathol 2007;16(4): 203-11.
• 28.Liu C, Rinderknecht H, Histing T, et al. Establishmentof an ın vitro scab model for ınvestigating different phasesof wound healing. Bioengineering (Basel) 2022; 9(5):191.
• 29. Koyuncu A, Koç S, Akdere OE, et al. Investigation of the synergistic effect of platelet-rich plasma andpolychromatic light on human dermal fibroblasts seededchitosan/gelatin scaffolds for wound healing. JPhotochem Photobiol B 2022; 232:112476.
• 30.Shi F, Sottile J. MT1-MMP regulates the turnover andendocytosis of extracellular matrix fibronectin. J Cell Sci2011; 124 (Pt 23): 4039-50.
• 31. Trojanowska M, LeRoy EC, Eckes B, et al. Pathogenesis of fibrosis: Type 1 collagen and the skin. J Mol Med (Berl)1998; 76: 266–274.
• 32.Volk SW, Wang Y, Mauldin EA, et al. Diminished typeIII collagen promotes myofibroblast differentiation andincreases scar deposition in cutaneous wound healing.Cells Tissues Organs 2011; 194: 25-37.
• 33.Black E, Vibe-Petersen J, Jorgensen LN, et al. Decreaseof collagen deposition in wound repair in type 1 diabetesindependent of glycemic control. Arch Surg 2003; 138:34-40.
• 34.Molina-Molina M, Machahua-Huamani C, Vicens-Zygmunt V, et al. Anti-fibrotic effects of pirfenidone andrapamycin in primary IPF fibroblasts and human alveolar epithelial cells. BMC Pulm Med 2018; 18: 63.